SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Christopher J. Coughlin

As a Name:  Registrant, Group Member and/or Signatory


        

Latest Filing:  4/2/24  as  Registrant


As:  Registrant

4/2/24  
 DE
 
Coughlin Christopher J


        

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

• List all Filings as Signatory
• Search Recent Filings (as Signatory) for “Christopher J. Coughlin

Christopher J. Coughlin” has been a Signatory for/with  5  Filers:


        
As OfFiler    Filings    
  #        Latest      
Issuer    
(Primary)    
In descending order 
2/22/24 
 MA
 
Karuna Therapeutics, Inc.  5  10-K  —
2/21/24 
 MO
 
Centene Corp.  4  S-3ASR  —
7/5/23 
 DE
 
Coughlin Christopher J  26  4 
 MO
 
Centene Corp.
5/5/23 
 NY
 
Prestige Consumer Healthcare Inc.  4  10-K  —
2/8/21 
 MA
 
Alexion Pharmaceuticals, Inc.  1  10-K  —

Christopher J. Coughlin” has/had a Signatory interest in  12  Issuers:

As OfIssuer    Filings    
  #        Latest      
With Filer    
(Primary)    
In descending order 
7/5/23 
 MO
 
Centene Corp.  3  4 
 DE
 
Coughlin Christopher J
4/28/20 
 MA
 
Karuna Therapeutics, Inc.  1  3 
 DE
 
Coughlin Christopher J
8/1/19 
 NY
 
Prestige Consumer Healthcare Inc.  1  3 
 DE
 
Coughlin Christopher J
5/17/19 
 MA
 
Alexion Pharmaceuticals, Inc.  1  4 
 DE
 
Coughlin Christopher J
5/4/18 
Flag of Ireland emoji
 
Allergan plc  2  4 
 DE
 
Coughlin Christopher J
3/4/16 
 MA
 
Hologic Inc.  1  3 
 DE
 
Coughlin Christopher J
12/15/15 
 NJ
 
Dun & Bradstreet Corp./NW  7  4 
 DE
 
Coughlin Christopher J
8/27/12 
 NY
 
Forest Laboratories, LLC  1  4 
 DE
 
Coughlin Christopher J
8/27/09 
Flag of Ireland emoji
 
Covidien plc  2  4 
 DE
 
Coughlin Christopher J
10/9/08 
Flag of Ireland emoji
 
Johnson Controls International plc  3  4 
 DE
 
Coughlin Christopher J
11/13/00 
 MO
 
Monsanto Co./New  2  4 
 DE
 
Coughlin Christopher J
5/15/00 
 NJ
 
Pharmacia Corp./DE  2  3/A 
 DE
 
Coughlin Christopher J

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 4:43:18.2pm ET